{"transactions":[{"id":739307,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:25.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001568850-26-000002","document":"form4-06122026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000156885026000002/form4-06122026_040607.xml","form_type":"4"}},{"id":739306,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:24.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001573553-26-000002","document":"form4-06122026_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000157355326000002/form4-06122026_040605.xml","form_type":"4"}},{"id":739304,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35319,"kind":"person","name":"Duty Stuart","position":1,"cik":"0001970274","reported_name":"Duty Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:22.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001970274-26-000004","document":"form4-06122026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000197027426000004/form4-06122026_040603.xml","form_type":"4"}},{"id":739305,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":20237,"kind":"person","name":"Wills Robert James","position":1,"cik":"0001634189","reported_name":"Wills Robert James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:20.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001634189-26-000002","document":"form4-06122026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000163418926000002/form4-06122026_040601.xml","form_type":"4"}},{"id":739303,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":36231,"kind":"person","name":"TOMSICEK MICHAEL JOHN","position":1,"cik":"0001570392","reported_name":"TOMSICEK MICHAEL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:19.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001570392-26-000003","document":"form4-06122026_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000157039226000003/form4-06122026_040614.xml","form_type":"4"}},{"id":739302,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35598,"kind":"person","name":"Saik Andrew","position":1,"cik":"0001616284","reported_name":"Saik Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:16.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001616284-26-000002","document":"form4-06122026_040612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000161628426000002/form4-06122026_040612.xml","form_type":"4"}},{"id":739495,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:14.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001242215-26-000014","document":"form4-06122026_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000014/form4-06122026_040609.xml","form_type":"4"}},{"id":804400,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-04-20T20:06:18.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":36500,"price":2.26,"value":82490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the range set forth in this footnote."}],"balance_after":446244,"source":{"system":"sec-edgar","filing":"0001437782-26-000010","document":"form4-04202026_080414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000010/form4-04202026_080414.xml","form_type":"4"}},{"id":917594,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T21:30:21.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":679000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":679000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":679000},"source":{"system":"sec-edgar","filing":"0001437782-26-000007","document":"form4a-02052026_040217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000007/form4a-02052026_040217.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":917453,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T21:30:18.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001943112-26-000005","document":"form4a-02052026_040212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000005/form4a-02052026_040212.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":917452,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T21:30:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001771207-26-000005","document":"form4a-02052026_040210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000005/form4a-02052026_040210.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":917451,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T21:30:12.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001787700-26-000005","document":"form4a-02052026_040208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000005/form4a-02052026_040208.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":918213,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-05T16:30:19.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price on the initial filings was incorrectly stated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001910985-26-000006","document":"form4a-02052026_040214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000006/form4a-02052026_040214.xml","form_type":"4/A","original_submission_date":"2026-02-04"}},{"id":919148,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:52:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001771207-26-000004","document":"form4-02042026_100201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000004/form4-02042026_100201.xml","form_type":"4"}},{"id":919147,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T22:52:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001771207-26-000004","document":"form4-02042026_100201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000004/form4-02042026_100201.xml","form_type":"4"}},{"id":919146,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:50:42.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001787700-26-000004","document":"form4-02042026_100239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000004/form4-02042026_100239.xml","form_type":"4"}},{"id":919145,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T22:50:42.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001787700-26-000004","document":"form4-02042026_100239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000004/form4-02042026_100239.xml","form_type":"4"}},{"id":919144,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:50:09.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001943112-26-000004","document":"form4-02042026_050205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000004/form4-02042026_050205.xml","form_type":"4"}},{"id":919143,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T22:50:09.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001943112-26-000004","document":"form4-02042026_050205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000004/form4-02042026_050205.xml","form_type":"4"}},{"id":919309,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:50:04.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":453000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":453000,"derivative":{"underlying":"Common Shares","underlying_shares":453000},"source":{"system":"sec-edgar","filing":"0001437782-26-000006","document":"form4-02042026_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000006/form4-02042026_050201.xml","form_type":"4"}},{"id":919308,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T22:50:04.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":679000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":679000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":679000},"source":{"system":"sec-edgar","filing":"0001437782-26-000006","document":"form4-02042026_050201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000006/form4-02042026_050201.xml","form_type":"4"}},{"id":920168,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T17:50:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":136000,"derivative":{"underlying":"Common Shares","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001910985-26-000005","document":"form4-02042026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000005/form4-02042026_050203.xml","form_type":"4"}},{"id":920167,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-04T17:50:06.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":204000,"derivative":{"exercise_price":1.97,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":204000},"source":{"system":"sec-edgar","filing":"0001910985-26-000005","document":"form4-02042026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000005/form4-02042026_050203.xml","form_type":"4"}},{"id":928806,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T23:30:10.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928805,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T23:30:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928804,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:10.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":12245,"price":1.93,"value":23632.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49848,"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928803,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:10.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":62093,"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928802,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:10.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":58007,"price":2.32,"value":134576.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":41993,"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928801,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:10.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001943112-26-000002","document":"form4-01282026_060107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000194311226000002/form4-01282026_060107.xml","form_type":"4"}},{"id":928800,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928799,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928798,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":11180,"price":1.93,"value":21577.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":205406,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928797,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":216586,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928796,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":53566,"price":2.32,"value":124273.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":196486,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928795,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:09.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":250052,"source":{"system":"sec-edgar","filing":"0001771207-26-000002","document":"form4-01282026_060105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120726000002/form4-01282026_060105.xml","form_type":"4"}},{"id":928794,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T23:30:07.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928793,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T23:30:07.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928792,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:07.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":12245,"price":1.93,"value":23632.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":99848,"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928791,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:07.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":112093,"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928790,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:07.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":58007,"price":2.32,"value":134576.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":91993,"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928789,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:07.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001787700-26-000002","document":"form4-01282026_060103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000178770026000002/form4-01282026_060103.xml","form_type":"4"}},{"id":928908,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T23:30:05.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":66600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":199800,"derivative":{"underlying":"Common Shares","underlying_shares":66600},"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":928907,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T23:30:05.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":280000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":928906,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:05.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":34523,"price":1.93,"value":66629.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":482744,"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":928905,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:05.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":66600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":517267,"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":928904,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:05.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":133054,"price":2.32,"value":308685.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":450667,"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":928903,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-28T23:30:05.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":280000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":583721,"source":{"system":"sec-edgar","filing":"0001437782-26-000004","document":"form4-01282026_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000004/form4-01282026_060101.xml","form_type":"4"}},{"id":929376,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":false,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"One-fourth (1/4th) of the shares subject to the RSU award vested or will vest on each of January 26, 2026, January 26, 2027, January 26, 2028 and January 26, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":60300,"derivative":{"underlying":"Common Shares","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929375,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the option will vest on June 12, 2026 and 50% will vest on December 12, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":100000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-05-06","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929374,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":12245,"price":1.93,"value":23632.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":113181,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929373,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2026-01-26","kind":"exercise","planned":false,"acquired":true,"shares":20100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each RSU represents a contingent right to receive one common share."}],"balance_after":125426,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929372,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":58007,"price":2.32,"value":134576.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of PSUs or restricted stock unit (\"RSU\") awards only, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105326,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":929371,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-28T18:30:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a performance stock unit (\"PSU\") award that vested upon the certification by the Compensation Committee of the Board of Directors of the Issuer that the U.S. Food and Drug Administration has provided a New Drug Application Approval Letter granting approval of Cardamyst (etripamil)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU represents a contingent right to receive one common share."}],"balance_after":163333,"source":{"system":"sec-edgar","filing":"0001910985-26-000003","document":"form4-01282026_060109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000191098526000003/form4-01282026_060109.xml","form_type":"4"}},{"id":942053,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-09T21:53:39.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":43000,"price":2.25,"value":96750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.265 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":303721,"source":{"system":"sec-edgar","filing":"0001437782-26-000002","document":"form4-01092026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000002/form4-01092026_090136.xml","form_type":"4"}},{"id":942052,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-01-09T21:53:39.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":500,"price":2.25,"value":1125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025."}],"balance_after":346721,"source":{"system":"sec-edgar","filing":"0001437782-26-000002","document":"form4-01092026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000143778226000002/form4-01092026_090136.xml","form_type":"4"}},{"id":972424,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2025-12-11T21:15:10.000Z","date":"2025-12-09","kind":"gift","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift for no consideration to members of the Reporting Person's family outside the Reporting Person's household."}],"balance_after":150052,"source":{"system":"sec-edgar","filing":"0001771207-25-000002","document":"form4-12112025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000177120725000002/form4-12112025_041204.xml","form_type":"4"}},{"id":1087247,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":16793,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":16793},"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1087246,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":16793,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":16793},"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1087245,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."}],"balance_after":16793,"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1087250,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:25.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":50000,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-019775","document":"form4-07152025_040722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019775/form4-07152025_040722.xml","form_type":"4"}},{"id":1087249,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:25.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":50000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-019775","document":"form4-07152025_040722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019775/form4-07152025_040722.xml","form_type":"4"}},{"id":1087248,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Common Shares","published_at":"2025-07-15T20:15:25.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-25-019775","document":"form4-07152025_040722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019775/form4-07152025_040722.xml","form_type":"4"}},{"id":1087244,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":20237,"kind":"person","name":"Wills Robert James","position":1,"cik":"0001634189","reported_name":"Wills Robert James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:23.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":50000,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-019774","document":"form4-07152025_040719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019774/form4-07152025_040719.xml","form_type":"4"}},{"id":1087243,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":20237,"kind":"person","name":"Wills Robert James","position":1,"cik":"0001634189","reported_name":"Wills Robert James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:23.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":50000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-019774","document":"form4-07152025_040719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019774/form4-07152025_040719.xml","form_type":"4"}},{"id":1087242,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":20237,"kind":"person","name":"Wills Robert James","position":1,"cik":"0001634189","reported_name":"Wills Robert James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-15T20:15:23.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock."}],"balance_after":65000,"source":{"system":"sec-edgar","filing":"0001415889-25-019774","document":"form4-07152025_040719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019774/form4-07152025_040719.xml","form_type":"4"}},{"id":1087333,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:17.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019772","document":"form4-07152025_040710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000141588925019772/form4-07152025_040710.xml","form_type":"4"}},{"id":1087332,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:17.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019772","document":"form4-07152025_040710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000141588925019772/form4-07152025_040710.xml","form_type":"4"}},{"id":1087331,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2025-07-15T20:15:17.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."}],"balance_after":347221,"source":{"system":"sec-edgar","filing":"0001415889-25-019772","document":"form4-07152025_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000141588925019772/form4-07152025_040710.xml","form_type":"4"}},{"id":1087240,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1087239,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":66666,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1087238,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2025-07-15T20:15:12.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 66,666 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 66,666 shares of common stock."}],"balance_after":175052,"source":{"system":"sec-edgar","filing":"0001415889-25-019771","document":"form4-07152025_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019771/form4-07152025_040705.xml","form_type":"4"}},{"id":1087296,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1087295,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1087294,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1087698,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":53333,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1087697,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":53333,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":53333},"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1087696,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2025-07-15T16:15:21.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":53333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 53,333 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 53,333 shares of common stock."}],"balance_after":63333,"source":{"system":"sec-edgar","filing":"0001415889-25-019773","document":"form4-07152025_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925019773/form4-07152025_040715.xml","form_type":"4"}},{"id":1112967,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35598,"kind":"person","name":"Saik Andrew","position":1,"cik":"0001616284","reported_name":"Saik Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:13.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016933","document":"form4-06122025_040612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016933/form4-06122025_040612.xml","form_type":"4"}},{"id":1112968,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:08.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016931","document":"form4-06122025_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016931/form4-06122025_040608.xml","form_type":"4"}},{"id":1112966,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016930","document":"form4-06122025_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016930/form4-06122025_040605.xml","form_type":"4"}},{"id":1113103,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016932","document":"form4-06122025_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925016932/form4-06122025_040611.xml","form_type":"4"}},{"id":1112965,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":20237,"kind":"person","name":"Wills Robert James","position":1,"cik":"0001634189","reported_name":"Wills Robert James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016935","document":"form4-06122025_040616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016935/form4-06122025_040616.xml","form_type":"4"}},{"id":1112964,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":36231,"kind":"person","name":"TOMSICEK MICHAEL JOHN","position":1,"cik":"0001570392","reported_name":"TOMSICEK MICHAEL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016934","document":"form4-06122025_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016934/form4-06122025_040614.xml","form_type":"4"}},{"id":1112963,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35319,"kind":"person","name":"Duty Stuart","position":1,"cik":"0001970274","reported_name":"Duty Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:03.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016929","document":"form4-06122025_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016929/form4-06122025_040603.xml","form_type":"4"}},{"id":1291688,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T21:15:17.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002269","document":"form4-01292025_040113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/form4-01292025_040113.xml","form_type":"4"}},{"id":1291687,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67561,"kind":"person","name":"Nelson Jeffrey Edward","position":1,"cik":"0001943112","reported_name":"Nelson Jeffrey Edward","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T21:15:17.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002269","document":"form4-01292025_040113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/form4-01292025_040113.xml","form_type":"4"}},{"id":1291686,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002267","document":"form4-01292025_040108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002267/form4-01292025_040108.xml","form_type":"4"}},{"id":1291685,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67559,"kind":"person","name":"Hasija Amit","position":1,"cik":"0001787700","reported_name":"Hasija Amit","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & EVP of Corp. Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002267","document":"form4-01292025_040108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002267/form4-01292025_040108.xml","form_type":"4"}},{"id":1291684,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002268","document":"form4-01292025_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002268/form4-01292025_040111.xml","form_type":"4"}},{"id":1291683,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67560,"kind":"person","name":"Muller Lorenz","position":1,"cik":"0001771207","reported_name":"Muller Lorenz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T21:15:15.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002268","document":"form4-01292025_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925002268/form4-01292025_040111.xml","form_type":"4"}},{"id":1291790,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T21:15:07.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":266400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":266400,"derivative":{"underlying":"Common Shares","underlying_shares":266400},"source":{"system":"sec-edgar","filing":"0001415889-25-002265","document":"form4-01292025_040104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000141588925002265/form4-01292025_040104.xml","form_type":"4"}},{"id":1291789,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":51938,"kind":"person","name":"Oliveto Joseph","position":1,"cik":"0001437782","reported_name":"Oliveto Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T21:15:07.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":399600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":399600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":399600},"source":{"system":"sec-edgar","filing":"0001415889-25-002265","document":"form4-01292025_040104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437782/000141588925002265/form4-01292025_040104.xml","form_type":"4"}},{"id":1292227,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-29T16:15:10.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":80400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one common share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80400,"derivative":{"underlying":"Common Shares","underlying_shares":80400},"source":{"system":"sec-edgar","filing":"0001415889-25-002266","document":"form4-01292025_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925002266/form4-01292025_040106.xml","form_type":"4"}},{"id":1292226,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":67615,"kind":"person","name":"Bharucha David","position":1,"cik":"0001910985","reported_name":"Bharucha David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T16:15:10.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":120600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120600,"derivative":{"exercise_price":2.02,"expiration_date":"2035-01-27","underlying":"Common Shares","underlying_shares":120600},"source":{"system":"sec-edgar","filing":"0001415889-25-002266","document":"form4-01292025_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1910985/000141588925002266/form4-01292025_040106.xml","form_type":"4"}},{"id":1413674,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:31:10.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on October 3, 2024, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":1.39,"expiration_date":"2034-09-03","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-24-022914","document":"form4-09052024_080906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588924022914/form4-09052024_080906.xml","form_type":"4"}},{"id":1419774,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35598,"kind":"person","name":"Saik Andrew","position":1,"cik":"0001616284","reported_name":"Saik Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:16.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022537","document":"form4-08292024_040813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022537/form4-08292024_040813.xml","form_type":"4"}},{"id":1419773,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":35319,"kind":"person","name":"Duty Stuart","position":1,"cik":"0001970274","reported_name":"Duty Stuart","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:14.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022536","document":"form4-08292024_040810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022536/form4-08292024_040810.xml","form_type":"4"}},{"id":1419772,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":38592,"kind":"person","name":"Giles Lisa M.","position":1,"cik":"0001568850","reported_name":"Giles Lisa M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:14.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022534","document":"form4-08292024_040806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022534/form4-08292024_040806.xml","form_type":"4"}},{"id":1419771,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:13.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022533","document":"form4-08292024_040804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022533/form4-08292024_040804.xml","form_type":"4"}},{"id":1419770,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":36231,"kind":"person","name":"TOMSICEK MICHAEL JOHN","position":1,"cik":"0001570392","reported_name":"TOMSICEK MICHAEL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:12.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022535","document":"form4-08292024_040808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022535/form4-08292024_040808.xml","form_type":"4"}}],"next_cursor":"2024-08-29T20:15:12.000000Z,1419770"}